Pathak Swati, Yadav Rajeshwar
Cardiacvascular Thoracic Surgery, Institute Of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Cardiovascular Thoracic Surgery, Institute Of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Cureus. 2022 Jul 28;14(7):e27401. doi: 10.7759/cureus.27401. eCollection 2022 Jul.
In developing countries, like the Indian subcontinent, population overload, malnutrition, poor socio-economic status of affected groups, and health care facilities affect the treatment outcome. Nowadays procedures such as percutaneous balloon mitral valvotomy (PBMV) and open heart mitral valve replacement are offered to patients with mitral stenosis. Whenever PBMV is unavailable due to financial constraints and open surgical management cannot be offered due to overburdened healthcare facilities, closed mitral valvotomy (CMV) provides an excellent choice for patients with favorable mitral valve pathology. Many centers do not practice CMV and thus this procedure is dying out. The young generation of surgeons are not been trained in CMV. The purpose of our study is to reenvision CMV and emphasize its vital role in mitral stenosis patient subsets like pregnant women and young adults. We reviewed the literature for various valvotomy techniques done for mitral valve stenosis and restenosis. Immediate and late outcomes were compared between the patients receiving Percutaneous balloon mitral valvotomy and closed mitral valvotomy. The immediate and late-term results are comparable for PBMV and CMV and no statistically significant difference exists. The post-PBMV Mitral valve area (MVA) ranged from 2.1 +/- 0.7 cm^2 to 2.3 +/-0.94 cm^2 and post CMV MVA ranged from 1.3+/-0.3 cm^2 to 2.2+/-0.85 cm^2. Complications developing in both techniques are also nearly similar. Operative mortality in CMV patients ranged from 1% to 4.2%, also observed in PBMV patients in various studies. Mitral Regurgitation occurred in both groups equally and ranged from 0.3% to 14%. Restenosis was observed in both groups in the range of 4% to 5%. High fetal loss of around 20% mortality was witnessed in pregnant mitral stenosis patients undergoing open heart surgery. It's time to re-envision CMV since it is providing substantial outcomes and remitting the need for open-heart surgery at a very low cost in patients with mitral stenosis with a pliable valve.
在发展中国家,如印度次大陆,人口过载、营养不良、受影响群体社会经济地位低下以及医疗保健设施等因素都会影响治疗效果。如今,经皮球囊二尖瓣成形术(PBMV)和心脏直视二尖瓣置换术等手术可供二尖瓣狭窄患者选择。每当因经济限制无法进行PBMV,且由于医疗保健设施负担过重而无法提供开放手术治疗时,闭式二尖瓣切开术(CMV)为二尖瓣病变适宜的患者提供了一个绝佳选择。许多中心不再开展CMV,因此该手术正逐渐被淘汰。年轻一代外科医生未接受过CMV培训。我们研究的目的是重新审视CMV,并强调其在二尖瓣狭窄患者亚组(如孕妇和年轻人)中的重要作用。我们查阅了有关二尖瓣狭窄和再狭窄所采用的各种瓣膜切开术技术的文献。比较了接受经皮球囊二尖瓣成形术和闭式二尖瓣切开术患者的近期和远期结果。PBMV和CMV的近期和远期结果具有可比性,不存在统计学上的显著差异。PBMV术后二尖瓣面积(MVA)范围为2.1±0.7平方厘米至2.3±0.94平方厘米,CMV术后MVA范围为1.3±0.3平方厘米至2.2±0.85平方厘米。两种技术所出现的并发症也几乎相似。CMV患者的手术死亡率为1%至4.2%,在各项研究的PBMV患者中也观察到这一情况。两组均同样出现二尖瓣反流,发生率为0.3%至14%。两组均观察到再狭窄发生率在4%至5%。接受心脏直视手术的二尖瓣狭窄孕妇出现高达20%的高胎儿死亡率。鉴于CMV能产生显著疗效,并能以极低的成本免除二尖瓣柔软的二尖瓣狭窄患者进行心脏直视手术的需求,是时候重新审视CMV了。